This inventor holds 1 USPTO granted patent. Top assignee: Farmak, A.s.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Marek Stancl: Innovator in Pharmaceutical Chemistry
Introduction
Marek Stancl is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative methods for drug preparation. His work exemplifies the intersection of science and practical application in the medical field.
Latest Patents
Marek Stancl holds a patent for a method titled "Method for preparing N-[4-(2-{[2-(4-methane sulfonamidophenoxy) ethyl] (methyl)amino}ethyl)phenyl]methanesulfonamide (dofetilide)." This patent describes a process for synthesizing 1-(4-methanesulfonamidophenoxy)-2-[N-(4-methanesulfonamidophenethyl)-N-methylamino]ethane (Dofetilide) through the sulfonylation of a specific compound. The innovative approach outlined in his patent has the potential to enhance the efficiency of drug production.
Career Highlights
Marek Stancl is currently employed at Farmak, a.s., where he continues to apply his expertise in pharmaceutical research and development. His work at the company has allowed him to collaborate with other professionals in the field, further advancing the development of new therapeutic agents.
Collaborations
Due to space constraints, the details of Marek Stancl's collaborations will not be included in this article.
Conclusion
Marek Stancl's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key figure in the field. His work not only advances scientific knowledge but also has practical implications for drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile